ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
Inês Mota, Enrico Patrucco, Cristina Mastini, Navin R. Mahadevan, Tran C. Thai, Elisa Bergaggio, Taek-Chin Cheong, Giulia C. Leonardi, Elif Karaca-Atabay, Marco Campisi, Teresa Poggio, Matteo Menotti, Chiara Ambrogio, Dario Livio Longo, Susan Klaeger, Hasmik Keshishian, Zsófia Sztupinszki, Zoltán Szállási, Derin B. Keskin, Jonathan S. Duke‐Cohan, Bruce B. Reinhold, Steven A. Carr, Catherine J. Wu, Kelly D. Moynihan, Darrell J. Irvine, David A. Barbie, Ellis L. Reinherz, Claudia Voena, Mark M. Awad, Rafael B. Blasco, Roberto Chiarle
Topics & Concepts
ImmunogenicityVaccinationPeptideCancer researchLung cancerPeptide vaccineMedicineVirologyImmunologyAntibodyOncologyBiologyBiochemistryEpitopeLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Research Studies